Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 17, 2013

View Archived Issues

Investigation of EPAC as a therapeutic target expands

A novel fusion protein inhibits IgE-mediated peanut allergy anaphylaxis in vitro and in vivo

French researchers design novel immunocytokines

ATR kinase inhibitors patented by Vertex Pharmaceuticals

Metabolys divulges novel glucose-lowering agents

Novel tyrosine-protein kinase SYK inhibitors reported in Takeda patent

Novartis patent reveals p53/Mdm2 interaction inhibitors

Incyte reports development of novel JAK inhibitors

TRPM7 inhibitors reported in NoNO patent

NIH launches program to find biomarkers for Parkinson's disease

Paladin Labs enters into agreement for novel neuroblastoma drug

QRxPharma and FDA confirm steps for resubmission of MoxDuo NDA

FDA will not meet action date for Ravicti NDA

FDA grants priority review for afatinib in NSCLC with an EGFR mutation

DTRA award supports PsiOxus' development of biodefense vaccine adjuvants

Health Canada approves Afinitor for advanced breast cancer

Novel inhibitor of JMJD2 histone demethylases reduces viral reactivation in vivo

siRNAs against serotonin 5-HT1A receptors produce antidepressant-like effects

Enrollment open in phase II study of Bendavia

Promising topline results from proof-of-concept burns trial of human skin substitute

FDA approves Protein Sciences' Flublok seasonal influenza vaccine

AT-13148 begins U.K. phase I study for cancer

Somatuline launched in Japan

Topline results from phase III heart failure study of Aranesp reported

Pierre Fabre and Maruho sign Japanese licensing agreement for pediatric beta-blocker

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...